Atlas Trials

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Clinical trial NCT07226713 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07226713
Sponsor
Medical College of Wisconsin
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2026-07-01
Primary completion
2029-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.